title: Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab.
authors.affiliation: Wallace H. Coulter Platelet Laboratory, Division of Hematology/Oncology, University of Miami School of Medicine, Miami, FL 33136, USA.
authors.forename: Wenche
authors.initials: W
authors.lastname: Jy
authors.forename: Teresa
authors.initials: T
authors.lastname: Gagliano-DeCesare
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Kett
authors.forename: Lawrence L
authors.initials: LL
authors.lastname: Horstman
authors.forename: Joaquin J
authors.initials: JJ
authors.lastname: Jimenez
authors.forename: Zoneddy
authors.initials: Z
authors.lastname: Ruiz-Dayao
authors.forename: Edgardop S
authors.initials: ES
authors.lastname: Santos
authors.forename: Yeon S
authors.initials: YS
authors.lastname: Ahn
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015119:Aminocaproic Acid / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000150:complications / Q000628:therapy*; D016175:B-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D018438:Blue Toe Syndrome / Q000209:etiology; D001919:Bradycardia / Q000628:therapy; D003131:Combined Modality Therapy; D003161:Compartment Syndromes / Q000209:etiology; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005167:Factor VII / Q000627:therapeutic use; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000627:therapeutic use; D015942:Factor VIIa; D005260:Female; D006406:Hematoma / Q000188:drug therapy / Q000601:surgery; D006470:Hemorrhage / Q000209:etiology* / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D010956:Plasmapheresis; D017713:Platelet Transfusion; D019106:Postoperative Hemorrhage / Q000188:drug therapy / Q000209:etiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D011994:Recombinant Proteins; D000069283:Rituximab; C078147:F8 protein, human; D005167:Factor VII; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa; D003894:Deamino Arginine Vasopressin; D015119:Aminocaproic Acid